Maze Therapeutics (MAZE) Other Gross PP&E Adjustments (2024 - 2026)

Maze Therapeutics has disclosed Other Gross PP&E Adjustments across 3 years of filings, most recently posting -$20.8 million for Q1 2026.

• Other Gross PP&E Adjustments for Q1 2026 came in at -$20.8 million, up 12.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$20.8 million (up 12.37% YoY), and the FY2025 annual result was $3.5 million, up 259.44% from the prior year.
• Other Gross PP&E Adjustments came in at -$20.8 million for Q1 2026 at Maze Therapeutics, down from $3.5 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.5 million in Q4 2025 to a low of -$23.7 million in Q1 2025.
• The 3-year median for Other Gross PP&E Adjustments is -$21.4 million (2025), against an average of -$14.6 million.
• Across the five-year window, Other Gross PP&E Adjustments soared 259.44% in 2025 and rose 12.37% in 2026, its largest moves.
• Maze Therapeutics' Other Gross PP&E Adjustments stood at -$2.2 million in 2024, then jumped by 259.44% to $3.5 million in 2025, then sank by 697.13% to -$20.8 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$20.8 million (Q1 2026), $3.5 million (Q4 2025), and -$22.0 million (Q3 2025), per Business Quant data.